Genomic Aberrations Associated With Outcome in Anaplastic Oligodendroglial Tumors Treated Within the EORTC Phase III Trial 26951

Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-010-0380-9

Related search